Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2750 of 3173 entries
View as:

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT03061201 Org: User:
Start: 06/21/17 End: 07/16/24 Due: 07/16/25

Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00373958 Org: User:
Start: 09/30/06 End: 06/30/08 Due: 06/30/09

A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02954653 Org: User:
Start: 11/28/16 End: 12/05/17 Due: 12/05/18

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01227564 Org: User:
Start: 02/28/11 End: 02/28/14 Due: 02/28/15

STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT

Phase: N/A Priority: Normal
NCT ID: NCT04616027 Org: User:
Start: 01/13/21 End: 02/18/22 Due: 02/18/23

A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Phase: N/A Priority: Normal
NCT ID: NCT05375929 Org: User:
Start: 07/16/22 End: 03/14/24 Due: 03/14/25

AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00076024 Org: User:
Start: 02/29/04 End: 11/30/08 Due: 11/30/09

Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population

Phase: N/A Priority: Normal
NCT ID: NCT04801420 Org: User:
Start: 03/08/21 End: 01/22/26 Due: 01/22/27

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00667810 Org: User:
Start: 06/30/08 End: 08/31/13 Due: 08/31/14

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00644449 Org: User:
Start: 01/31/03 End: 03/31/04 Due: 03/31/05

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

Phase: N/A Priority: Normal
NCT ID: NCT06634836 Org: User:
Start: 03/17/25 End: 12/31/25 Due: 12/31/26

A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03985293 Org: User:
Start: 10/15/19 End: 07/07/21 Due: 07/07/22

Precedex Special Investigation (in Pediatric Patients)

Phase: N/A Priority: Normal
NCT ID: NCT04040439 Org: User:
Start: 07/30/19 End: 08/08/22 Due: 08/08/23

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00751127 Org: User:
Start: 01/31/93 End: 02/28/94 Due: 02/28/95

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Phase: N/A Priority: Normal
NCT ID: NCT00161798 Org: User:
Start: 09/30/01 End: 03/31/02 Due: 03/31/03

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Phase: N/A Priority: Normal
NCT ID: NCT01970865 Org: User:
Start: 01/08/14 End: 05/24/23 Due: 05/24/24

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Phase: N/A Priority: Normal
NCT ID: NCT06125522 Org: User:
Start: 01/10/24 End: 11/03/25 Due: 11/03/26

A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT05732428 Org: User:
Start: 02/20/23 End: 11/01/24 Due: 11/01/25

Non Interventional Study For Patients Treated With Somavert®

Phase: N/A Priority: Normal
NCT ID: NCT00858143 Org: User:
Start: 01/31/04 End: 01/31/08 Due: 01/31/09

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Phase: N/A Priority: Normal
NCT ID: NCT00788294 Org: User:
Start: 11/30/08 End: 06/30/09 Due: 06/30/10

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

Phase: N/A Priority: Normal
NCT ID: NCT00914459 Org: User:
Start: 12/31/09 End: 04/30/16 Due: 04/30/17

Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002040 Org: User:
Start: - End: - Due: -

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00483756 Org: User:
Start: 08/31/07 End: 04/30/10 Due: 04/30/11

Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01103726 Org: User:
Start: 05/31/10 End: 11/30/11 Due: 11/30/12

A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01468714 Org: User:
Start: 10/31/11 End: 10/31/11 Due: 10/31/12